In conclusion, patients with oligometastasis who are treated with targeted therapy, such as EGFR-TKI and ALK-TKI, in conjunction with local therapy, may have better efficacy.12 However, reports of tumor downstaging resulting from the elimination of metastases by EGFR-TKI are uncommon. Here, ALK is linked to neoplasm.